Understanding Metformin Use During Pregnancy

Overview of Metformin

Metformin is a commonly prescribed medication for managing type 2 diabetes, a condition characterized by the body’s decreasing sensitivity to insulin. Insulin, a vital hormone, facilitates the storage of sugar from food and its transport to fat and muscle cells for future energy use. In contrast to type 1 diabetes, where the body fails to produce insulin, individuals with type 2 diabetes gradually develop resistance to its effects. This resistance can lead to numerous health complications.

Insulin’s Role in Fertility

In addition to its functions in energy regulation, insulin plays a significant role in fertility. Hormones such as estrogen and testosterone are influenced by insulin levels in the bloodstream, which can affect various developmental stages, including puberty. Elevated insulin levels may lead to early onset of puberty. Consequently, metformin is utilized to manage several fertility-related issues, including infertility and polycystic ovary syndrome. The medication is also effective in treating gestational diabetes, a form of diabetes that arises during pregnancy.

Research on Metformin and Pregnancy

Despite its widespread use, the effects of metformin during pregnancy remain inadequately understood, raising concerns about potential impacts on the developing fetus. Butalia and colleagues conducted a comprehensive review published in Diabetic Medicine, analyzing 16 clinical trials involving a total of 2,165 participants. These studies compared outcomes for pregnant women treated with metformin against those treated with insulin.

Findings from the Clinical Review

The review revealed no significant differences in preterm birth rates or fetal malformations between the metformin and insulin treatment groups. Notably, metformin was associated with a reduced risk of low blood sugar in newborns and fewer admissions to the neonatal intensive care unit (NICU), an important consideration as low blood sugar can lead to severe complications such as seizures.

Furthermore, the use of metformin did not correlate with an increased risk of maternal or infant mortality, nor did it elevate rates of Caesarean sections. While metformin was found to lower the likelihood of high blood pressure, it did not impact the occurrence of pre-eclampsia. Mothers treated with metformin also experienced less weight gain during pregnancy.

Impact on Birth Weight and Child Development

Metformin was effective in reducing the incidence of high birth weight babies, which can pose challenges during delivery and increase the risk of obesity and diabetes in later life. However, it did not influence the rates of low birth weight. At 18 months, children born to mothers who used metformin during pregnancy were larger and heavier compared to those whose mothers were treated with insulin, although no cognitive differences were observed between the two groups.

Conclusions and Future Research Directions

Butalia and colleagues concluded that metformin is a safe alternative to insulin for managing diabetes during pregnancy. However, they noted that the studies analyzed had relatively small sample sizes, indicating a need for further research. Future studies should focus on the long-term effects of metformin exposure in children born to mothers treated with the drug during pregnancy.

Written By: C. I. Villamil